Search for: "MYLAN PHARMACEUTICAL CO., INC."
Results 81 - 100
of 215
Sorted by Relevance
|
Sort by Date
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
28 Aug 2013, 10:31 am
By Dennis Crouch Leo Pharmaceutical Products, Ltd. v. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
6 Nov 2015, 6:58 am
Mylan and Actavis were seeking revocation of the patent. [read post]
31 May 2012, 7:50 am
Mylan Pharmaceuticals, Inc., Mylan, Inc. [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
21 Feb 2014, 8:53 am
Mylan, Inc., 911 F. [read post]
25 Aug 2010, 12:37 am
Perrigo Co. et al. [read post]
16 May 2012, 12:22 pm
Mylan Pharmaceuticals, Inc., ___ F. [read post]
28 Jul 2010, 12:06 am
K-V Pharmaceutical Co. et al. [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
18 Feb 2010, 10:34 am
Mylan followed Sandoz Pharmaceuticals Corp. v. [read post]
18 Jul 2012, 4:52 am
In the pharmaceutical field, for example, a patent can be granted based on in vitro results. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
30 Nov 2021, 9:36 am
Mylan Pharma Inc. [read post]
17 Oct 2013, 5:00 am
Mutual Pharmaceutical Co., 731 F. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
